NCT00255762View on ClinicalTrials.gov

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2006

Conditions
Recurrent MelanomaStage IV Melanoma
Interventions
DRUG

carboplatin

Given IV

DRUG

paclitaxel

Given IV

BIOLOGICAL

bevacizumab

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

North Central Cancer Treatment Group, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00255762 - Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter